Ignite Creation Date:
2025-12-24 @ 4:46 PM
Ignite Modification Date:
2026-02-25 @ 7:27 PM
Study NCT ID:
NCT02105350
Status:
WITHDRAWN
Last Update Posted:
2018-02-19
First Post:
2014-04-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of MEK162 With Gemcitabine and Oxaliplatin in Biliary Cancer
Sponsor:
University Health Network, Toronto
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Biliary GEMOX / MEK
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None